Alligator Bioscience AB News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.09.20	Alligator Bioscience launches a new immuno-oncology concept (PR Newswire)
24.09.20	Alligator Bioscience launches a new immuno-oncology concept (PR Newswire)
16.09.20	Alligator Bioscience receives patent approval for the drug candidate ATOR-1015 (PR Newswire)
16.09.20	Alligator Bioscience receives patent approval for the drug candidate ATOR-1015 (PR Newswire)
09.09.20	Alligator Bioscience presents an update regarding the Phase I study with the drug candidate ATOR-1015 (PR Newswire)
09.09.20	Alligator Bioscience presents an update regarding the Phase I study with the drug candidate ATOR-1015 (PR Newswire)
04.09.20	Alligator Bioscience presents positive biomarker data demonstrating proof of mechanism in mitazalimab clinical Phase I study (PR Newswire)
04.09.20	Alligator Bioscience presents positive biomarker data demonstrating proof of mechanism in mitazalimab clinical Phase I study (PR Newswire)
27.08.20	Alligator Bioscience: Encouraging interim safety data in ATOR-1017 clinical Phase I study (PR Newswire)
27.08.20	Alligator Bioscience: Encouraging interim safety data in ATOR-1017 clinical Phase I study (PR Newswire)
25.08.20	Alligator Bioscience Virtual R&D Day - August 27, 2020 (PR Newswire)
25.08.20	Alligator Bioscience Virtual R&D Day - August 27, 2020 (PR Newswire)
25.08.20	Alligator Bioscience presents the clinical project portfolio at Virtual R&D Day August 27, 2020 (PR Newswire)
25.08.20	Alligator Bioscience presents the clinical project portfolio at Virtual R&D Day August 27, 2020 (PR Newswire)
13.07.20	Alligator Bioscience AB (publ) Interim Report January-June 2020 (PR Newswire)
13.07.20	Alligator Bioscience AB (publ) Interim Report January-June 2020 (PR Newswire)
15.06.20	Alligator Bioscience Appoints New CFO (PR Newswire)
15.06.20	Alligator Bioscience Appoints New CFO (PR Newswire)
10.06.20	Aptevo Therapeutics and Alligator Bioscience Present new Preclinical Data for ALG.APV-527 at the PEGS Virtual Interactive Global Summit (PR Newswire)
10.06.20	Aptevo Therapeutics and Alligator Bioscience Present new Preclinical Data for ALG.APV-527 at the PEGS Virtual Interactive Global Summit (PR Newswire)
04.06.20	Alligator Bioscience and Scandion Oncology Sign Preclinical Agreement to Explore Combination Therapies for Chemotherapy and Immuno-oncology (PR Newswire)
04.06.20	Alligator Bioscience and Scandion Oncology Sign Preclinical Agreement to Explore Combination Therapies for Chemotherapy and Immuno-oncology (PR Newswire)
01.06.20	Alligator Bioscience's Collaboration With Biotheus Inc. Proceeds and Second Payment is Received (PR Newswire)
01.06.20	Alligator Bioscience's Collaboration With Biotheus Inc. Proceeds and Second Payment is Received (PR Newswire)
29.05.20	Alligator Bioscience Presents Novel Supportive Phase I Data at ASCO for its CTLA-4 x OX40 Bispecific Drug Candidate ATOR-1015 (PR Newswire)
29.05.20	Alligator Bioscience Presents Novel Supportive Phase I Data at ASCO for its CTLA-4 x OX40 Bispecific Drug Candidate ATOR-1015 (PR Newswire)
27.04.20	Alligator Bioscience Presents Promising Interim Phase I Data for its Bispecific Drug Candidate ATOR-1015 at AACR (PR Newswire)
27.04.20	Alligator Bioscience Presents Promising Interim Phase I Data for its Bispecific Drug Candidate ATOR-1015 at AACR (PR Newswire)
23.04.20	Alligator Bioscience AB (publ) Interim Report January-March 2020 (PR Newswire)
23.04.20	Alligator Bioscience AB (publ) Interim Report January-March 2020 (PR Newswire)
20.04.20	Alligator Bioscience's Board of Directors Reduces its Fees and Offers Possibility for Postal Voting in Front of the Annual General Meeting (PR Newswire)
20.04.20	Alligator Bioscience's Board of Directors Reduces its Fees and Offers Possibility for Postal Voting in Front of the Annual General Meeting (PR Newswire)
07.04.20	Alligator Bioscience Increases Focus on Clinical Development (PR Newswire)
07.04.20	Alligator Bioscience Increases Focus on Clinical Development (PR Newswire)
01.04.20	Alligator Bioscience Informs About Temporary Halt of Recruitment of New Patients due to the COVID-19 Pandemic (PR Newswire)
01.04.20	Alligator Bioscience Informs About Temporary Halt of Recruitment of New Patients due to the COVID-19 Pandemic (PR Newswire)
31.03.20	Notice of Annual General Meeting in Alligator Bioscience AB (publ) (PR Newswire)
31.03.20	Notice of Annual General Meeting in Alligator Bioscience AB (publ) (PR Newswire)
05.03.20	Alligator Bioscience Appoints Andreas Johannesson as interim Chief Financial Officer (PR Newswire)
05.03.20	Alligator Bioscience Appoints Andreas Johannesson as interim Chief Financial Officer (PR Newswire)
02.03.20	Alligator Bioscience's Annual Report 2019 Published (PR Newswire)
02.03.20	Alligator Bioscience's Annual Report 2019 Published (PR Newswire)
12.02.20	Alligator Bioscience AB Year-end Report January-December 2019 (PR Newswire)
12.02.20	Alligator Bioscience AB Year-end Report January-December 2019 (PR Newswire)
17.12.19	Alligator Bioscience: First Patient Dosed With ATOR-1017 Developed for Metastasized Cancer (PR Newswire)
17.12.19	Alligator Bioscience: First Patient Dosed With ATOR-1017 Developed for Metastasized Cancer (PR Newswire)
29.11.19	Alligator Bioscience AB Appoints Chief Operating Officer (PR Newswire)
29.11.19	Alligator Bioscience AB Appoints Chief Operating Officer (PR Newswire)
08.11.19	Aptevo Therapeutics and Alligator Bioscience Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer 2019 Annual Meeting (PR Newswire)
08.11.19	Aptevo Therapeutics and Alligator Bioscience Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer 2019 Annual Meeting (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Alligator Bioscience AB

Aktien Top/Flop

Meistgelesene Nachrichten